Back to MAVERICK CAPITAL LTD MAVERICK CAPITAL LTD

NAMSNAMS
7 quarters

Position history for MAVERICK CAPITAL LTDMAVERICK CAPITAL LTD's holdings in NewAmsterdam Pharma Company N.V.

MAVERICK CAPITAL LTD holds 3.3M shares of NAMS (NewAmsterdam Pharma Company N.V.), worth $110.7M as of 2026-Q2. The position was increased (+49.5% shares). NAMS represents 1.0% of MAVERICK CAPITAL LTD's portfolio.

Current Value

$110.7M

Current Shares

3.3M

Total Value Change

+$101.8M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.3M
+49.5%
$110.7M1.0%$33.89
58
2026-Q1
Increased
2.2M
+15.4%
$70M0.8%$30.41
48
2025-Q4
Increased
1.9M
+25.9%
$66.4M0.7%$34.74
51
2025-Q3
Decreased
1.5M
-1.8%
$42.8M0.6%$27.52
0
2025-Q2
Increased
1.5M
+178.8%
$27.7M0.4%$18.57
55
2025-Q1
Increased
549,469
+57.0%
$11.2M0.2%$21.76
47
2024-Q4
New
350,005
-
$9M0.2%$25.60
46

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used